Tag:
fostamatinib
Latest Headlines
Latest Headlines
Will AstraZeneca get out the checkbook in search of new programs?
Within 24 hours of the news that AstraZeneca ( $AZN ) had experienced back-to-back pipeline setbacks, the pharma giant had countered the news with new deals aimed at adding early- and mid-stage
